2.2 Standardized NHSN Criteria for Healthcare-Associated Infections

2.2 Standardized NHSN Criteria for Healthcare-Associated Infections

The National Healthcare Safety Network (NHSN), managed by the CDC, is the nation's most widely used healthcare-associated infection tracking system. NHSN provides standardized surveillance definitions that healthcare facilities use to track HAIs, guide prevention efforts, and fulfill federal reporting mandates (such as CMS Quality Reporting Programs). To ensure consistency nationwide, NHSN surveillance criteria rely on precise operational rules, temporal windows, and objective diagnostic parameters.

---

1. Universal NHSN Operational Rules

Before applying specific infection definitions, IPs must master NHSN's core foundational concepts:

• Infection Window Period (IWP): A 7-calendar-day period defined as the 3 calendar days before, the day of, and the 3 calendar days after the collection date of the first positive diagnostic test (microbiology culture, molecular test, or imaging) used to satisfy an NHSN infection criterion.
• Date of Event (DOE): The date when the last element used to satisfy the NHSN infection criterion occurred within the IWP.
• Repeat Infection Timeframe (RIT): A 14-calendar-day timeframe during which no new HAI of the same type can be reported. The RIT begins on the Date of Event (Day 1). Additional positive cultures or clinical symptoms meeting the same infection definition during the RIT are treated as part of the initial episode.
• Device Association Rule: An HAI is device-associated if an eligible invasive device (central line, urinary catheter, or ventilator) was in place for more than 2 calendar days on the Date of Event (where Day 1 is the day of device placement), AND the device was present on the Date of Event or the day before.

---

2. Central Line-Associated Bloodstream Infection (CLABSI)

A CLABSI is a primary bloodstream infection (BSI) where an eligible central line was in place for $> 2$ calendar days on the Date of Event. A central line is defined as an intravascular catheter that terminates at or near the heart or in one of the great vessels.

Criteria Categories

1. Laboratory-Confirmed Bloodstream Infection 1 (LCBI-1): Patient has a recognized pathogen isolated from one or more blood cultures (e.g., Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans) AND the organism is not related to an infection at another site.
2. Laboratory-Confirmed Bloodstream Infection 2 (LCBI-2): Patient has fever ($> 38.0^\circ\text{C}$), chills, or hypotension AND the same common commensal organism (e.g., Coagulase-negative Staphylococci, Viridans group streptococci) is isolated from two or more blood cultures drawn on the same or consecutive days.
3. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection (MBI-LCBI): A subset of LCBI occurring in severely immunocompromised patients (e.g., allogeneic hematopoietic stem cell transplant recipients with grade III/IV graft-versus-host disease or severe neutropenia with absolute neutrophil count $\text{ANC} < 500/\mu\text{L}$). Organisms are restricted to mucosal translocation flora (e.g., Enterococcus spp., Escherichia coli, Klebsiella spp.). Classifying an event as MBI-LCBI prevents penalizing central line care quality in populations where bloodstream invasion stems from intestinal mucosal breakdown.

---

3. Catheter-Associated Urinary Tract Infection (CAUTI)

A CAUTI occurs when an indwelling urinary catheter was in place for $> 2$ calendar days on the Date of Event, and the patient meets all of the following NHSN criteria:

NHSN CAUTI Diagnostic Criteria

1. Device Exposure: Indwelling urinary catheter in place for $> 2$ calendar days on the Date of Event (and present on DOE or the day prior).
2. Clinical Signs/Symptoms: Patient exhibits at least one of the following: fever ($> 38.0^\circ\text{C}$), suprapubic tenderness, costovertebral angle pain or tenderness, urinary urgency, frequency, or dysuria (note: urgency, frequency, and dysuria cannot be used if an indwelling catheter is still in place).
3. Microbiological Criterion: Urine culture showing $\ge 10^5 \text{ CFU/mL}$ of no more than 2 species of microorganisms.

Critical Exclusions:

• Asymptomatic Bacteriuria (ASB): High colony counts without clinical symptoms do NOT meet CAUTI criteria and must not be reported as HAIs.
• Fungal Uropathogens: Since 2015, Candida species and other yeasts/fungi are strictly excluded from NHSN CAUTI surveillance, regardless of colony count or clinical symptoms.

---

4. Surgical Site Infection (SSI)

SSI surveillance tracks infections occurring post-operatively following NHSN operative procedures. SSIs are classified into three anatomical depth tiers:

Depth Classifications

• Superficial Incisional SSI: Involves only skin and subcutaneous tissue of the incision. Must occur within 30 days of the procedure.
• Deep Incisional SSI: Involves deep soft tissues (e.g., fascial and muscle layers). Must meet surveillance window criteria.
• Organ/Space SSI: Involves any part of the body deeper than fascial/muscle layers opened or manipulated during the operative procedure (e.g., intra-abdominal abscess post-colectomy).

Surveillance Observation Windows

• 30-Day Surveillance Window: Applies to all superficial incisional SSIs and to deep incisional/organ-space SSIs following procedures without foreign body implants (e.g., appendectomy, cholecystectomy, colon surgery).
• 90-Day Surveillance Window: Applies to deep incisional or organ-space SSIs following specified NHSN procedures involving implants or high-risk prosthetic materials (e.g., coronary artery bypass graft [CABG], joint arthroplasty [KPRO/HPRO], spinal fusion, breast surgery).

---

5. Ventilator-Associated Events (VAE)

VAE surveillance applies to adult inpatient units ($18+$ years) and utilizes an objective, tiered diagnostic algorithm to eliminate subjective clinical interpretation of ventilator-associated pneumonia (VAP).

                             [ Tier 1: VAC ]
                 Worsening oxygenation after stability
                                   │
                                   ▼
                            [ Tier 2: IVAC ]
               VAC + Temperature/WBC abnormality + New Antibiotics
                                   │
                                   ▼
                            [ Tier 3: PVAP ]
             IVAC + Purulent Secretions OR Positive Culture/Diagnostic

The Three VAE Tiers

1. Ventilator-Associated Complication (VAC): Patient has $\ge 2$ calendar days of stable or improving oxygenation (baseline), followed by worsening oxygenation defined as an increase in daily minimum $\text{FiO}_2$ of $\ge 0.20$ ($20\text{ points}$) OR an increase in daily minimum PEEP of $\ge 3 \text{ cm H}_2\text{O}$, sustained for $\ge 2$ calendar days.
2. Infectious Ventilator-Associated Complication (IVAC): Patient meets VAC criteria AND exhibits general evidence of infection: temperature $> 38.0^\circ\text{C}$ or $< 36.0^\circ\text{C}$ OR $\text{WBC} \ge 12,000$ or $\le 4,000/\mu\text{L}$, AND a new qualifying antimicrobial agent is initiated and continued for $\ge 4$ consecutive calendar days.
3. Possible Ventilator-Associated Pneumonia (PVAP): Patient meets IVAC criteria AND demonstrates diagnostic lab evidence: purulent respiratory secretions ($\ge 25$ neutrophils and $\le 10$ squamous epithelial cells per low-power field) OR a positive quantitative respiratory culture (e.g., BAL $\ge 10^4 \text{ CFU/mL}$).

---

6. Laboratory-Identified (LabID) Event Surveillance

LabID event surveillance monitors Clostridioides difficile infection (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia relying strictly on laboratory data without clinical chart review.

• Healthcare Facility-Onset (HO): Specimen collected $> 3$ calendar days after admission to the facility (where Day 1 is the day of admission).
• Community-Onset (CO): Specimen collected $\le 3$ calendar days after admission.
• 14-Day Duplicate Rule: Any subsequent positive specimen of the same pathogen collected within 14 calendar days of an initial positive result for the same patient in the same location is treated as a duplicate and excluded.